JP2004533846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004533846A5 JP2004533846A5 JP2003512262A JP2003512262A JP2004533846A5 JP 2004533846 A5 JP2004533846 A5 JP 2004533846A5 JP 2003512262 A JP2003512262 A JP 2003512262A JP 2003512262 A JP2003512262 A JP 2003512262A JP 2004533846 A5 JP2004533846 A5 JP 2004533846A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acid
- seq
- substantially pure
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 47
- 125000003275 alpha amino acid group Chemical group 0.000 claims 22
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 230000005907 cancer growth Effects 0.000 claims 6
- 208000006454 hepatitis Diseases 0.000 claims 6
- 231100000283 hepatitis Toxicity 0.000 claims 6
- 208000002672 hepatitis B Diseases 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 6
- 201000008383 nephritis Diseases 0.000 claims 6
- 230000005965 immune activity Effects 0.000 claims 5
- 230000002068 genetic effect Effects 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 208000026278 immune system disease Diseases 0.000 claims 2
- 244000005700 microbiome Species 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90449201A | 2001-07-13 | 2001-07-13 | |
| PCT/GB2002/003203 WO2003006492A2 (en) | 2001-07-13 | 2002-07-11 | Biologically active peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007187713A Division JP2007312785A (ja) | 2001-07-13 | 2007-07-19 | 生物学的に活性なペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004533846A JP2004533846A (ja) | 2004-11-11 |
| JP2004533846A5 true JP2004533846A5 (enExample) | 2008-06-26 |
| JP4213581B2 JP4213581B2 (ja) | 2009-01-21 |
Family
ID=25419251
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003512262A Expired - Fee Related JP4213581B2 (ja) | 2001-07-13 | 2002-07-11 | 生物学的に活性なペプチド |
| JP2007187713A Pending JP2007312785A (ja) | 2001-07-13 | 2007-07-19 | 生物学的に活性なペプチド |
| JP2008140488A Expired - Fee Related JP4316651B2 (ja) | 2001-07-13 | 2008-05-29 | 生物学的に活性なペプチド |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007187713A Pending JP2007312785A (ja) | 2001-07-13 | 2007-07-19 | 生物学的に活性なペプチド |
| JP2008140488A Expired - Fee Related JP4316651B2 (ja) | 2001-07-13 | 2008-05-29 | 生物学的に活性なペプチド |
Country Status (23)
| Country | Link |
|---|---|
| EP (3) | EP1947109A3 (enExample) |
| JP (3) | JP4213581B2 (enExample) |
| KR (2) | KR100889993B1 (enExample) |
| AT (2) | ATE414099T1 (enExample) |
| AU (1) | AU2002319423B2 (enExample) |
| BR (1) | BR0210252A (enExample) |
| CA (2) | CA2452417C (enExample) |
| DE (2) | DE60236330D1 (enExample) |
| DK (2) | DK1790655T3 (enExample) |
| ES (2) | ES2345842T3 (enExample) |
| IL (2) | IL159827A0 (enExample) |
| MX (1) | MXPA03011190A (enExample) |
| MY (1) | MY138219A (enExample) |
| NO (2) | NO332061B1 (enExample) |
| NZ (3) | NZ553507A (enExample) |
| PL (2) | PL211884B1 (enExample) |
| PT (2) | PT1790655E (enExample) |
| RU (2) | RU2425053C2 (enExample) |
| SA (1) | SA04240478B1 (enExample) |
| SG (2) | SG142165A1 (enExample) |
| UA (1) | UA83989C2 (enExample) |
| WO (1) | WO2003006492A2 (enExample) |
| ZA (2) | ZA200401108B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1223602C (zh) | 2001-07-13 | 2005-10-19 | 一泰医药研究（深圳）有限公司 | 序列号11的生物活性肽 |
| US20060167229A1 (en) * | 2002-12-18 | 2006-07-27 | Wai Ming Wong | Biologically active peptide conjugates |
| TWI322815B (en) * | 2003-06-26 | 2010-04-01 | Cms Peptides Patent Holding Company Ltd | Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |
| TWI353252B (en) * | 2004-04-28 | 2011-12-01 | Cms Peptides Patent Holding Company Ltd | Biologically active peptide vapeehptllteaplnpk der |
| CN1799623B (zh) * | 2005-01-05 | 2011-01-26 | 康哲医药研究(深圳)有限公司 | 生物活性肽在制备用于防治关节炎的药物中的用途 |
| RU2423375C2 (ru) | 2005-07-26 | 2011-07-10 | СиЭмЭс ПЕПТАЙДЗ ПЭЙТЕНТ ХОЛДИНГ КОМПАНИ ЛИМИТЕД | Новые биологически активные пептиды и их новое применение |
| GB0918579D0 (en) * | 2009-10-22 | 2009-12-09 | Imp Innovations Ltd | Gadd45beta targeting agents |
| RU2429005C1 (ru) * | 2010-10-07 | 2011-09-20 | Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН | Способ стимуляции противоопухолевой активности цитотоксических эффекторов иммунной системы |
| RU2615908C1 (ru) * | 2016-05-16 | 2017-04-11 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ моделирования лимфогенного и гематогенного метастазирования мышиной меланомы В16 у белых нелинейных крыс |
| TWI890506B (zh) * | 2024-06-27 | 2025-07-11 | 開曼群島商味丹國際（控股）有限公司 | 具有抑制ace活性之胜肽及其組合物 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242821A (en) | 1989-07-10 | 1993-09-07 | Valio, Finnish Co-Operative Dairies' Association | Lactococcus promoter and signal sequences for expression in bacteria |
| IT1231156B (it) | 1989-07-19 | 1991-11-19 | Eniricerche Spa | Espressione e secrezione di interleuchina 1 beta umana matura in bacillus subtilis e mezzi e metodi per il suo ottenimento. |
| WO1991009613A1 (en) * | 1989-12-22 | 1991-07-11 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Synthetic peptides as modulators of functional responses of intact cells |
| US5556744A (en) * | 1992-05-29 | 1996-09-17 | The Trustees Of The University Of Pennsylvania | Methods and compositions for diagnosing and treating certain HIV infected patients |
| DE69433299T2 (de) | 1993-06-15 | 2004-09-09 | E.I. Du Pont De Nemours And Co., Wilmington | Rekombinante spinnerseide analoge |
| JP3286420B2 (ja) | 1993-09-28 | 2002-05-27 | 株式会社ユニシアジェックス | 内燃機関の吸排気弁駆動制御装置 |
| AU2631695A (en) | 1994-06-17 | 1996-01-15 | Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno | Method for introduction of genetic material into microorganisms and transformants obtained therewith |
| US6184208B1 (en) | 1994-06-29 | 2001-02-06 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| US5958416A (en) * | 1994-12-16 | 1999-09-28 | Regents Of The University Of Minnesota | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
| IL115199A (en) | 1995-09-07 | 2005-05-17 | Opperbas Holding Bv | Composition comprising a polynucleic acid molecule in a liposome and method using said composition |
| ATE273322T1 (de) | 1995-10-24 | 2004-08-15 | Chemo Sero Therapeut Res Inst | Tfpi-verwandte peptide die das wachstums von glatten muskelzellen inhibieren |
| GB9606016D0 (en) * | 1996-03-22 | 1996-05-22 | Smithkline Beecham Plc | Novel use |
| US5861483A (en) * | 1996-04-03 | 1999-01-19 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
| SE9603468D0 (sv) * | 1996-09-23 | 1996-09-23 | Astra Ab | New compounds |
| GB9710762D0 (en) * | 1997-05-23 | 1997-07-23 | Cancer Res Inst Royal | Binding complexes |
| EP1015612B1 (en) | 1997-05-27 | 2005-01-26 | Hanil Synthetic Fiber Co., Ltd. | Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae |
| KR19990024297A (ko) | 1997-08-07 | 1999-04-06 | 오종석 | 인체 구강내 치태형성을 억제하는 신규한 유산균 |
| US6100388A (en) | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
| US6245427B1 (en) | 1998-07-06 | 2001-06-12 | DüZGüNES NEJAT | Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles |
| JP2002523114A (ja) * | 1998-08-31 | 2002-07-30 | ユニバーシテイ オブ ワシントン | バイオポリマーの分析のための安定なアイソトープ代謝性ラベリング |
| US6413530B1 (en) * | 1999-04-21 | 2002-07-02 | University Of Florida Research Foundation, Inc. | Pesticidal peptides |
| FR2794370B1 (fr) * | 1999-06-03 | 2003-10-17 | Biovector Therapeutics | Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination |
| AU1197001A (en) * | 1999-10-29 | 2001-05-14 | Institute For Applied Biomedicine | B cell clonal toxins and methods for using the same |
-
2002
- 2002-07-11 KR KR1020047000499A patent/KR100889993B1/ko not_active Expired - Fee Related
- 2002-07-11 DK DK07000950.1T patent/DK1790655T3/da active
- 2002-07-11 ES ES07000950T patent/ES2345842T3/es not_active Expired - Lifetime
- 2002-07-11 PL PL383101A patent/PL211884B1/pl unknown
- 2002-07-11 EP EP08005150A patent/EP1947109A3/en not_active Withdrawn
- 2002-07-11 PT PT07000950T patent/PT1790655E/pt unknown
- 2002-07-11 RU RU2007108896/10A patent/RU2425053C2/ru not_active IP Right Cessation
- 2002-07-11 DK DK02749008T patent/DK1478659T3/da active
- 2002-07-11 WO PCT/GB2002/003203 patent/WO2003006492A2/en not_active Ceased
- 2002-07-11 EP EP02749008A patent/EP1478659B1/en not_active Expired - Lifetime
- 2002-07-11 AU AU2002319423A patent/AU2002319423B2/en not_active Ceased
- 2002-07-11 SG SG200508362-1A patent/SG142165A1/en unknown
- 2002-07-11 MY MYPI20022635A patent/MY138219A/en unknown
- 2002-07-11 IL IL15982702A patent/IL159827A0/xx active IP Right Grant
- 2002-07-11 RU RU2004104335/13A patent/RU2305107C2/ru active
- 2002-07-11 ES ES02749008T patent/ES2316586T3/es not_active Expired - Lifetime
- 2002-07-11 KR KR1020077013319A patent/KR100889992B1/ko not_active Expired - Fee Related
- 2002-07-11 PL PL368059A patent/PL208666B1/pl unknown
- 2002-07-11 AT AT02749008T patent/ATE414099T1/de not_active IP Right Cessation
- 2002-07-11 DE DE60236330T patent/DE60236330D1/de not_active Expired - Lifetime
- 2002-07-11 DE DE60229883T patent/DE60229883D1/de not_active Expired - Lifetime
- 2002-07-11 BR BR0210252-8A patent/BR0210252A/pt active Search and Examination
- 2002-07-11 UA UA2004021049A patent/UA83989C2/ru unknown
- 2002-07-11 AT AT07000950T patent/ATE466871T1/de not_active IP Right Cessation
- 2002-07-11 NZ NZ553507A patent/NZ553507A/en not_active IP Right Cessation
- 2002-07-11 CA CA2452417A patent/CA2452417C/en not_active Expired - Lifetime
- 2002-07-11 MX MXPA03011190A patent/MXPA03011190A/es active IP Right Grant
- 2002-07-11 CA CA2707767A patent/CA2707767C/en not_active Expired - Fee Related
- 2002-07-11 SG SG2010039980A patent/SG185137A1/en unknown
- 2002-07-11 PT PT02749008T patent/PT1478659E/pt unknown
- 2002-07-11 NZ NZ529879A patent/NZ529879A/en not_active IP Right Cessation
- 2002-07-11 EP EP07000950A patent/EP1790655B1/en not_active Expired - Lifetime
- 2002-07-11 JP JP2003512262A patent/JP4213581B2/ja not_active Expired - Fee Related
- 2002-07-11 NZ NZ544079A patent/NZ544079A/en not_active IP Right Cessation
-
2004
- 2004-01-12 NO NO20040134A patent/NO332061B1/no not_active IP Right Cessation
- 2004-01-17 SA SA04240478A patent/SA04240478B1/ar unknown
- 2004-02-11 ZA ZA200401108A patent/ZA200401108B/en unknown
-
2005
- 2005-12-05 ZA ZA200509838A patent/ZA200509838B/xx unknown
-
2007
- 2007-06-26 IL IL184227A patent/IL184227A/en not_active IP Right Cessation
- 2007-07-19 JP JP2007187713A patent/JP2007312785A/ja active Pending
- 2007-07-25 NO NO20073914A patent/NO20073914L/no not_active Application Discontinuation
-
2008
- 2008-05-29 JP JP2008140488A patent/JP4316651B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100815408B1 (ko) | 만성 간염용 치료 백신으로서의 안정화된 ＨＢｃ 키메라입자 | |
| JP2004531242A5 (enExample) | ||
| CA2413546A1 (en) | Modification of hepatitis b core antigen | |
| US7504107B2 (en) | Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response | |
| JP2002528060A5 (enExample) | ||
| JP2005511076A5 (enExample) | ||
| Kossovsky et al. | Surface-modified nanocrystalline ceramics for drug delivery applications | |
| JPH01279842A (ja) | Ａ型及びｂ型肝炎混合アジュバントワクチン | |
| JP2002542827A5 (enExample) | ||
| JP2004533846A5 (enExample) | ||
| JP2001518304A5 (enExample) | ||
| CA2395499A1 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| JPH06504785A (ja) | インターロイキン−１０による腫瘍性疾患の処置 | |
| JP2003509018A5 (enExample) | ||
| CN1405181A (zh) | 血清白蛋白与干扰素的融合蛋白 | |
| CN1637013A (zh) | 具有改善的免疫调节功能的经修饰的CpG寡聚脱氧核苷酸 | |
| CN101463089B (zh) | 人血清白蛋白-干扰素融合蛋白及其编码基因与应用 | |
| JP2006502228A5 (enExample) | ||
| RU2004104335A (ru) | Биологически активные пептиды | |
| JP2005512518A5 (enExample) | ||
| JP2018533908A5 (enExample) | ||
| CN1056816A (zh) | 改良的疫苗组合物 | |
| JP2004538275A5 (enExample) | ||
| DE60313437D1 (de) | Mhc klasse i peptidepitope des humanen tumorassoziierten antigens 5t4 | |
| SK59393A3 (en) | Use of il-4 to enhance immune response to immunogegens in vaccines |